GILD · News · 20260823N

Revenue Performance and Mix

GILEAD SCIENCES, INC. · 2026-08-23 · Importance 37 · Surprise 6 · In source text

Gilead Sciences reported second-quarter revenue of approximately $7.80 billion. The quarterly revenue exceeded analyst estimates, representing a material revenue figure relative to the company’s stated revenue base. The digest does not provide a YoY or sequential revenue comparison or a product-level mix breakdown.

Key facts

• Gilead Sciences reported strong quarterly revenue of $7.80 billion, exceeding estimates. source
• Commerce Bank acquired 281,297 shares of Gilead Sciences, Inc. for approximately $35.5 million in the second quarter. source
• Evolve Private Wealth LLC acquired a new stake of 20,202 shares in Gilead Sciences, Inc. valued at approximately $2,552,000 during the second quarter. source
• Daiichi Life Insurance Co. Ltd. acquired 183,684 shares of Gilead Sciences, Inc. for approximately $23.21 million during the second quarter. source
• Elevation Point Wealth Partners LLC acquired a new stake of 27,671 shares, valued at approximately $3.496 million, in Gilead Sciences, Inc. during the second quarter. source
• Varma Mutual Pension Insurance Co acquired a new position in Gilead Sciences, Inc. during the second quarter, valued at approximately $26.34 million. source
• WealthShield Partners LLC purchased 13,549 shares of Gilead Sciences, Inc. valued at approximately $1,712,000 during the second quarter. source
• Kendall Capital Management purchased 8,362 shares of Gilead Sciences, Inc. during the second quarter, an investment of $1.06 million. source

Impact estimates